Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 62

1.

Re: Anticholinergic Therapy vs. OnabotulinumtoxinA for Urgency Urinary Incontinence.

Wein AJ.

J Urol. 2013 Mar;189(3):1000. doi: 10.1016/j.juro.2012.11.102. Epub 2013 Jan 22. No abstract available.

PMID:
23394655
3.

Re: OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.

Cornu JN.

Eur Urol. 2017 Jun;71(6):988-989. doi: 10.1016/j.eururo.2017.02.013. Epub 2017 Feb 27. No abstract available.

PMID:
28249800
4.

Re: OnabotulinumtoxinA vs Sacral Neuromodulation on Refractory Urgency Urinary Incontinence in Women: A Randomized Clinical Trial.

Wein AJ.

J Urol. 2017 Jun;197(6):1524-1525. doi: 10.1016/j.juro.2017.03.100. Epub 2017 Mar 17. No abstract available.

PMID:
28505919
5.

Cost-effectiveness analysis of newer anticholinergic drugs for urinary incontinence vs oxybutynin and no treatment using data on persistence from the Swedish prescribed drug registry.

Nilsson FO, Linnér L, Samuelsson E, Milsom I.

BJU Int. 2012 Jul;110(2):240-6. doi: 10.1111/j.1464-410X.2011.10729.x. Epub 2011 Nov 17.

6.

Efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: a randomised, double-blind, placebo-controlled trial.

Cruz F, Herschorn S, Aliotta P, Brin M, Thompson C, Lam W, Daniell G, Heesakkers J, Haag-Molkenteller C.

Eur Urol. 2011 Oct;60(4):742-50. doi: 10.1016/j.eururo.2011.07.002. Epub 2011 Jul 13.

PMID:
21798658
7.

Long-term efficacy and safety of onabotulinumtoxinA in patients with urinary incontinence due to neurogenic detrusor overactivity: an interim analysis.

Kennelly M, Dmochowski R, Ethans K, Karsenty G, Schulte-Baukloh H, Jenkins B, Thompson C, Li D, Haag-Molkenteller C.

Urology. 2013 Mar;81(3):491-7. doi: 10.1016/j.urology.2012.11.010. Epub 2013 Jan 3.

8.

Treatment satisfaction and goal attainment with onabotulinumtoxinA in patients with incontinence due to idiopathic OAB.

Brubaker L, Gousse A, Sand P, Thompson C, Patel V, Zhou J, Jenkins B, Sievert KD.

Int Urogynecol J. 2012 Aug;23(8):1017-25. doi: 10.1007/s00192-011-1655-1. Epub 2012 Jan 25.

PMID:
22273813
9.

Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy.

Minaglia S, Ozel B, Bizhang R, Mishell DR Jr.

Urology. 2005 Oct;66(4):702-6.

PMID:
16230120
10.

[Obstruction following surgical repair of female stress urinary incontinence. Diagnosis and treatment].

Romero Maroto J, Prieto Chaparro L, López López C, Quilez Fenoll JM, Rodríguez Fernández E.

Arch Esp Urol. 2002 Nov;55(9):1107-14. Spanish.

PMID:
12564070
12.

Frequency of de novo urgency in 463 women who had undergone the tension-free vaginal tape (TVT) procedure for genuine stress urinary incontinence--a long-term follow-up.

Holmgren C, Nilsson S, Lanner L, Hellberg D.

Eur J Obstet Gynecol Reprod Biol. 2007 May;132(1):121-5. Epub 2006 Jul 3.

PMID:
16815624
13.

Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis.

Lee JK, Dwyer PL, Rosamilia A, Lim YN, Polyakov A, Stav K.

BJOG. 2011 Jun;118(7):798-805. doi: 10.1111/j.1471-0528.2011.02915.x. Epub 2011 Mar 10.

14.

Urgency and urge incontinence in an older population: ten-year changes and their association with mortality.

Nuotio M, Tammela TL, Luukkaala T, Jylhä M.

Aging Clin Exp Res. 2002 Oct;14(5):412-9.

PMID:
12602577
15.

Drug therapy of urinary urge incontinence: a systematic review.

Haeusler G, Leitich H, van Trotsenburg M, Kaider A, Tempfer CB.

Obstet Gynecol. 2002 Nov;100(5 Pt 1):1003-16. Review.

PMID:
12423868
16.

Pharmacological management of women with mixed urinary incontinence.

Hashim H, Abrams P.

Drugs. 2006;66(5):591-606. Review.

PMID:
16620139
17.

Stress urinary incontinence and overactive bladder syndrome: current options and new targets for management.

Elser DM.

Postgrad Med. 2012 May;124(3):42-9. doi: 10.3810/pgm.2012.05.2547. Review.

PMID:
22691898
18.

Urinary incontinence-pathophysiology and management outline.

Santiagu SK, Arianayagam M, Wang A, Rashid P.

Aust Fam Physician. 2008 Mar;37(3):106-10. Review.

PMID:
18345357
19.

Six-year follow-up and predictors of urgency-associated urinary incontinence and bowel symptoms among the oldest old: a population-based study.

Nuotio M, Luukkaala T, Tammela TL, Jylhä M.

Arch Gerontol Geriatr. 2009 Sep-Oct;49(2):e85-90. doi: 10.1016/j.archger.2008.08.009. Epub 2008 Dec 5.

PMID:
19058863
20.

Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence.

Roehrborn CG, Abrams P, Rovner ES, Kaplan SA, Herschorn S, Guan Z.

BJU Int. 2006 May;97(5):1003-6.

Supplemental Content

Support Center